évolocumab
Tue, 03 Oct 2023 10:15:01 -0400
Tue, 03 Oct 2023 10:15:01 -0400
Newtown, Pennsylvania, KVK-Tech, Inc. is voluntarily recalling one lot (Batch Number: 17853A; “the batch”) of Betaxolol Tablets, USP 10 mg, White, Round, film coated biconvex tablets, debossed “K” above bisect “13” on one side and plain on the other side” to the consumer level. The batch was distrib
Charlottesville, VA - Biomic Sciences is voluntarily recalling all lots of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray products to the consumer level. FDA testing found the product to contain microbial contamination identified as Microbacterium sp., Fictibacillus sp., Bacillus sp.,
Hospira, Inc., a Pfizer company, is voluntarily recalling the lots listed in the table below of 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10mL vial; 1% Lidocaine HCl Injection, USP,
50 mg/5mL vial; and 2% Lidocaine HCl Injection, USP, 100 mg/5mL vial to the user level. The recall was initiated d
Charlottesville, VA - Biomic Sciences is voluntarily recalling all lots of ION* Sinus Support, ION* Sinus, and Restore Sinus Spray products to the consumer level. FDA testing found the product to contain microbial contamination identified as Microbacterium sp., Fictibacillus sp., Bacillus sp.,
Fri, 29 Sep 2023 23:31:36 -0400
Dans le traitement du cancer de la prostate avancéchez l'adulte.
Fri, 29 Sep 2023 14:41:46 -0400
Fri, 29 Sep 2023 09:29:46 -0400
Dans le traitement du lymphome B diffus à grandes cellules réfractaire ou récidivant (LBDGC) non spécifié, du LBDGC naissant d’un lymphome indolent, du lymphome B de haut grade (LBHG), du lymphome médiastinal primitif à cellules B (LMPCB) ou du lymphome folliculaire de grade 3B, réfractaire ou récidivant, chez l’adulte ayant déjà reçu au moins deux traitements à action générale et qui ne peuvent pas recevoir de thérapie par cellules CAR-T ou ont déjà reçu ce type de thérapie.
Certain surgical respirators, surgical masks, and pediatric face masks by O&M Halyard do not meet quality and performance expectations.
The U.S. Food and Drug Administration (FDA) is providing important safety information to healthcare providers on the use of products containing live bacteria or yeast (commonly called probiotics) in preterm infants in hospital settings.
80.211.154.110